Johnson & Johnson stands by “positive benefit/risk profile” of its Covid-19 vaccine
From CNN s Jacqueline Howard
A pharmacist volunteer prepares doses of the Johnson and Johnson COVID-19 vaccine during a pop-up clinic in Detroit, Michigan, on April 12. Matthew Hatcher/Getty Images
Johnson & Johnson believes that the benefits of its coronavirus vaccine outweigh the risks, Dr. Paul Stoffels, the company s chief scientific officer, said during an earnings call on Tuesday morning.
Last week, the US Centers for Disease Control and Prevention and the US Food and Drug Administration recommended pausing the use of the J&J Covid-19 vaccine over six reported US cases of a rare and severe type of blood clot” out of almost seven million doses administered.
Coronavirus update: Latest vaccine and world news
cnn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnn.com Daily Mail and Mail on Sunday newspapers.
阿根廷新增27001例新冠肺炎确诊病例 累计确诊近258万例
sina.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.cn Daily Mail and Mail on Sunday newspapers.